Amanda Nizam on biomarkers of TRAEs associated with EV for advanced urothelial carcinoma – GU Oncology Now

Amanda Nizam, a Genitourinary Medical Oncologist at Cleveland Clinic, recently shared a post by GU Oncology Now, on X/Twitter, adding:

“Thank you GU Oncology Now for the opportunity to discuss our study from UNITE examining the association between somatic alterations and EV TRAEs in patients with advanced urothelial carcinoma, presented at ESMO23.”

Quoting Gu Oncology Now’s post:

“We spoke with Amanda Nizam who provided an overview of her recent research on biomarkers of TRAEs associated with EV for advanced urothelial carcinoma, as well as results of the UNITE study and some of its biggest takeaways. Watch here.”

See more here.
For the article click here.
Sources: Amanda Nizam/X and GU Oncology Now/X